These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38231237)

  • 1. Synergistic effects of achieving perinatal interventions on bronchopulmonary dysplasia in preterm infants.
    Chen X; Yuan L; Jiang S; Gu X; Lei X; Hu L; Xiao T; Zhu Y; Dang D; Li W; Cao Y; Du L; Lee SK; Chen C; Zhou W; Zhou J;
    Eur J Pediatr; 2024 Apr; 183(4):1711-1721. PubMed ID: 38231237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors that affect the degree of bronchopulmonary dysplasia in very preterm infants: a 5-year retrospective study.
    Yang T; Shen Q; Wang S; Dong T; Liang L; Xu F; He Y; Li C; Luo F; Liang J; Tang C; Yang J
    BMC Pediatr; 2022 Apr; 22(1):200. PubMed ID: 35413820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
    Manley BJ; Kamlin COF; Donath S; Huang L; Birch P; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Wilson R; Davis PG; McKinlay CJD
    Trials; 2023 May; 24(1):320. PubMed ID: 37161488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
    Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
    Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.
    Ramos-Navarro C; Sánchez-Luna M; Zeballos-Sarrato S; González-Pacheco N
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2704-2710. PubMed ID: 30526187
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
    Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
    Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation.
    Härtel C; Herting E; Humberg A; Hanke K; Mehler K; Keller T; Mauer I; Frieauff E; Meyer S; Thome UH; Wieg C; Schmidtke S; Kribs A; Göpel W;
    JAMA Netw Open; 2022 Aug; 5(8):e2225810. PubMed ID: 35943742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outcomes and care practices of extremely preterm infants at 22-25 weeks' gestation age from the Chinese Neonatal Network].
    Jiang SY; Yang CZ; Tian XY; Chen DM; Yang ZM; Shi JY; Xu FL; Mo Y; Gu XY; Lee K; Zhou WH; Cao Y
    Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):22-28. PubMed ID: 38154973
    [No Abstract]   [Full Text] [Related]  

  • 10. Intratracheal Instillation of Budesonide-Surfactant for Prevention of Bronchopulmonary Dysplasia in Extremely Premature Infants.
    Dolma K; Zayek M; Gurung A; Eyal F
    Am J Perinatol; 2024 May; 41(S 01):e3065-e3073. PubMed ID: 37913780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
    Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
    BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early prediction of moderate to severe bronchopulmonary dysplasia in extremely premature infants.
    Sharma A; Xin Y; Chen X; Sood BG
    Pediatr Neonatol; 2020 Jun; 61(3):290-299. PubMed ID: 32217025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
    Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for severe bronchopulmonary dysplasia in a Chinese cohort of very preterm infants.
    Huang J; Shen W; Wu F; Mao J; Liu L; Chang Y; Zhang R; Ye X; Qiu Y; Ma L; Cheng R; Wu H; Chen D; Chen L; Xu P; Mei H; Wang S; Xu F; Ju R; Zheng Z; Lin X; Tong X
    Saudi Med J; 2024 Apr; 45(4):369-378. PubMed ID: 38657990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome.
    Sibrecht G; Kearl CR; Borys F; Morariu M; Bruschettini M; Soll R
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013158. PubMed ID: 37882216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short-term outcomes and their related risk factors of extremely preterm and extremely low birth weight infants in Guangdong province].
    Collaborative Study Group for Extremely Preterm and Extremely Low Birth Weight Infants
    Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):934-942. PubMed ID: 31795560
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery room resuscitation and short-term outcomes of extremely preterm and extremely low birth weight infants: a multicenter survey in North China.
    Li SJ; Feng Q; Tian XY; Zhou Y; Ji Y; Li YM; Zhai SF; Guo W; Zhang F; Zheng RX; He HY; Liu X; Wang JY; Mei H; Wang HY; Xie H; Zeng CM; Ma L; Zhang PP; Li JY; Wang XY; Li LH; Cui H; Yang SL; Chen L; Gu XH; Hu YJ; Que SS; Sun LX; Yang M; Zhao WL; Ma QY; Wang HJ; Guo JY
    Chin Med J (Engl); 2021 Jun; 134(13):1561-1568. PubMed ID: 34133350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Time Interval between Extubation and Reintubation on Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Shalish W; Kanbar L; Kovacs L; Chawla S; Keszler M; Rao S; Panaitescu B; Laliberte A; Precup D; Brown K; Kearney RE; Sant'Anna GM
    J Pediatr; 2019 Feb; 205():70-76.e2. PubMed ID: 30404739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
    JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.